TNF and neurosarcoidosis: Including our study, we identified 25 studies reporting 406 patients diagnosed with neurosarcoidosis and treated with TNF-α antagonists (7, 16, 19–28, 36, 39, 41, 42, 44–53) (Supplementary Table 3).